Charles A Vernau

Senior Investment Leader with VC, PE & Global Capital Markets Expertise | Early- to Growth-Stage Specialization | Skills in Market Strategy, Due Diligence, Value Creation, Relationship Building & Business Development

📍 New York, New York, United States🔄 Updated September 2026💼 28 investments📅 9 years investing🗓 Last invested Jun 2025
VC🌍 United States20+ investments
28
Total investments
6
Early stage
12
Mid stage
5
Late stage
9y
Years active

Portfolio

26 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Nov 2024
Life Biosciences is dedicated to developing novel therapies to extend healthy human lifespan by targeting the biological causes of aging. Founded in 2017 and headquartered in Boston, MA, we are pursuing therapies targeting three molecular pathways that regulate the biology of aging: mitochondrial uncoupling, chaperone-mediated autophagy, and epigenetic reprogramming. Our platform approach enables us to develop medicines with the potential to prevent, treat, and/or reverse multiple aging-related diseases, each with critical unmet needs.
late stageBiotechnology
Investor
May 2024
Biofire Technologies is on a mission to give gun owners better tools for reducing preventable gun injuries and deaths, especially among children. We believe our technology, combined with a best-in-class customer experience, will define the future of firearms safety for the next generation. Our mission-driven approach has earned support from the firearm community, the tech world, and the media. Biofire employees are world-class engineers who have designed and tested firearms, medical devices, robots, cars, satellites, rockets, and supersonic jets. What unites our team is our commitment to safety and reliability that we bring to our work every day. Since CEO Kai Kloepfer founded Biofire in 2016, the company has won respect and accolades from gun owners and supporters who believe in technology’s potential to help reduce firearm accidents, criminal misuse, suicides and other tragic outcomes.
late stageDefense & Space
Investor
Feb 2024
Figure is an AI Robotics company building the worlds first commercially viable autonomous humanoid robot. We are based in San Jose, CA.
Investor
Aug 2023
Revolutionizing our grid through ground-breaking plasma boring technology, creating tunnels for Fiber, Energy, Water, Gas, Vehicles, Pedestrians, and High-Speed Transit.
late stageUtilities
Investor
Nov 2021
me&u is used by 6000+ bars, pubs, and restaurants to create memorable guest experiences and grow their brands.
mid stageHospitality
Investor
Jul 2021
To achieve net-zero by 2050, the global hyperloop network is an indispensable piece of the puzzle. We enable convenient and sustainable high-speed transportation for everyone with the global hyperloop network. In the hyperloop, vehicles travel autonomously through a network of low-pressure tubes. Every trip is direct towards your destination without any stops in between. For the users, departures are on-demand, with transport times a fraction of what is offered by other modalities, while pricing is competitive. For the infrastructure owners, hyperloop is easy to integrate into the environment, has low energy consumption and emissions, and has a low total cost of ownership. We are Hardt Hyperloop. We envision a world where you can live, work and be, wherever you want, whenever you want. You have the world and everything it has to offer within arm’s reach. Join us in building future-proof transportation for a sustainable and hyper-connected world.
Investor
May 2021
Unlocking the full potential of ambitious businesses worldwide with $5k-$20m of purpose-built working capital. Todays fast-growing businesses need a capital provider that keeps pace with their ambitions. Traditional financing options are slow, cumbersome, and often out of reach. Thats why we built Wayflyer. Our unique technology can assess your growth potential to deliver tailored financing options in minutes, not months. Since launching in April 2020, weve deployed over $6 billion to 6,000+ businesses globally, backed by leading investors like QED, Left Lane Capital and DST Global. Were a fast-growing, venture-backed startup with big ambitions. From our offices in Dublin, London, Berlin, New York, Charlotte and Sydney, were serving consumer brands, retail outlets, software companies, service providers and beyond.
Investor
Mar 2021
Join the MonetaGo community here: https://www.monetago.com/home/#join-mailing-list MonetaGo is a provider of best-in-class fraud detection and prevention solutions. The MonetaGo Secure Financing system facilitates digitalization and reduces risk in trade finance. Secure Financing is a multi-module trade finance operating system that combines digitization and fraud prevention solutions, by leveraging encryption and confidential computing technology. Its Secure Financing systems enables banks, traditional financiers, non-bank financial institutions, fintechs, and trade finance funds to check for duplication and authentication of financing requests linked to invoices, bills of lading, air waybills, warehouse receipts, purchase orders, and other trade-related documents. By reducing fraud in trade finance, MonetaGo’s business activities align with worldwide political and regulatory mandates that empower institutions to sustain supply chains and extend their books of business into new markets and to underserved sectors, all while maintaining privacy and enabling critical real-time decision making. MonetaGo’s award-winning Secure Financing solution is available to financiers globally via multiple connectivity methods, including Swift.
Investor
Mar 2021
Contraline is a venture-backed, clinical-stage biotechnology company at the forefront of male contraception.
Investor
Jan 2021
Ixana is a wearable hardware company developing a distributed network of high-speed Human-Computer Interfaces.
Investor
Dec 2020
At Natilus we develop hyper-efficient blended wing body aircraft designed to make air travel more sustainable and to improve the economics of commercial aviation. Our family of innovative aircraft delivers exceptional fuel efficiency, higher payloads and works with today’s airport infrastructure.
Investor
Oct 2020
TapRm is the nations premier e-commerce solution for beer and hard seltzer brands. Through its e-commerce platform, TapRm helps brands grow and scale with direct-to-consumer tools and website integrations to deliver customers a superior experience that includes same day delivery, great pricing, industry leading quality assurance, data analytics, all while adhering to the three-tier system. TapRms marketplace (TapRm.com) also brings together the community of drinkers looking to discover the newest and most interesting brands making a splash in the beer industry. By simplifying a complex alcohol industry all under one easy to use platform, TapRm frees brands to focus on growth.
early stageManufacturing
Investor
Aug 2020
Farcast, Inc is a Los Angeles based technology company developing hardware and software to enable precision airdrop deliveries. We take a commercial airplane and through the door we autonomously release and land packages within a helipad-size area. Our technology allows commercial cargo to be safely delivered in remote, rural, or previously inaccessible areas, quickly and affordably.
Investor
Jul 2020
Grabango is the leading provider of checkout-free technology for existing, large-scale store chains. Grabango delivers a next-generation shopper experience and is the only enterprise-class, checkout-free solution on the market today. The Grabango platform is a fault-tolerant, edge computing network that accurately processes millions of simultaneous transactions. The system places no limits on who can enter the store, what can be sold there, or how the shelving is configured. For more information, visit www.grabango.com.
Show all 26 investments ↓
Experience · 42 entries
All (42)
Investments (28)
Founder (1)
2025
Venture Partner and LP
Nov 2025
Inception Studio Capital backs the world’s most experienced founders building the future of AI. Founded by John Whaley (Stanford PhD, Forbes AI 50, 3x founder) and Mike Morris (28-year Silicon Valley veteran with three acquisitions and an IPO), we are an early-stage venture fund investing in AI-native companies at the moment of inception. Our edge comes from Inception Studio—the most selective founder community in Silicon Valley for experienced AI builders. Through our zero-equity, high-trust retreats and buildathons, we attract serial entrepreneurs, exited founders, and senior technologists ready to start their next company. Because we take no equity upfront, we eliminate adverse selection and build deep relationships before investing. The results speak for themselves: • 235 experienced founders • 82% repeat entrepreneurs, 32% with prior exits • 42 companies launched, raising $164M+ from top VCs (a16z, Khosla, etc.) • Founder NPS 84 Our funding model is simple: • $100K starter checks in ~40 companies • $500K–$1.5M follow-on checks in 12 winners • With MFN and pro-rata rights to double down on breakout successes We focus exclusively on AI-native startups—founders building real, defensible products that transform how industries work, not just “AI features.” Our founders are experienced operators solving hard problems in domains like healthcare, legal, industrial automation, and human-computer interaction. At Inception, we believe the next generation of $10B AI companies won’t come from dorm rooms—they’ll come from experienced builders who have been here before.
Venture Partner and LP
Nov 2025
Backing generational technical founders at inception.
2024
Investor
Nov 2024
Life Biosciences is dedicated to developing novel therapies to extend healthy human lifespan by targeting the biological causes of aging. Founded in 2017 and headquartered in Boston, MA, we are pursuing therapies targeting three molecular pathways that regulate the biology of aging: mitochondrial uncoupling, chaperone-mediated autophagy, and epigenetic reprogramming. Our platform approach enables us to develop medicines with the potential to prevent, treat, and/or reverse multiple aging-related diseases, each with critical unmet needs.
late stageBiotechnology
Investor
May 2024
Biofire Technologies is on a mission to give gun owners better tools for reducing preventable gun injuries and deaths, especially among children. We believe our technology, combined with a best-in-class customer experience, will define the future of firearms safety for the next generation. Our mission-driven approach has earned support from the firearm community, the tech world, and the media. Biofire employees are world-class engineers who have designed and tested firearms, medical devices, robots, cars, satellites, rockets, and supersonic jets. What unites our team is our commitment to safety and reliability that we bring to our work every day. Since CEO Kai Kloepfer founded Biofire in 2016, the company has won respect and accolades from gun owners and supporters who believe in technology’s potential to help reduce firearm accidents, criminal misuse, suicides and other tragic outcomes.
late stageDefense & Space
Show all 42 entries ↓
Investment activity
2017–2025 · 28 investments
201712019120201420216202312024420251
Recent (last 2 years)Earlier